Sigma Lithium shares rose more than 4% after the US close today, after a Brazilian federal appeals court overturned the ...

Lamb Weston beat first-quarter profit forecasts and raised its full-year outlook, with North American volume growth leading ...

Marvell Technology raised its fiscal 2028 revenue target to about $20bn at its investor day, above analyst forecasts, sending ...

Telecom Plus says multi-service customer growth is running at roughly three times the FY26 rate, and it has held FY27 ...

Celebrus Technologies has guided this year's revenue and profit below what it believes the market expects, blaming slower new deals and an early customer ...

Clarkson shares are up about 6.4% in early London trading today, changing hands at 5375p, in the first move of this size in the 321 sessions of history ...

Cykel AI's interim results show £4,360 of revenue, a £1.18m loss and negative equity, after the AI agent developer dropped ...

UK shares opened higher today as a tech-led Wall Street rally towards record highs outweighed worries about the Iran war, though bond pressure in Britain ...

Schroder Japan Trust's net asset value rose 41.2% in the year to the 31st of July, ahead of the TOPIX. A narrowing discount lifted the share price return ...

HgCapital Trust is selling its whole stake in fund administrator Gen II to KKR for about £71m, 34% above its carrying value, ...

AstraZeneca has completed a $2bn investment in US biotech Summit Therapeutics, taking a stake of about 12% and opening a route to test its cancer drug conjugates alongside Summit’s ivonescimab.

Cenovus Energy has agreed to buy Athabasca Oil for C$12.00 a share, mostly in cash, in a deal valuing the oil sands producer at C$5.7bn including debt. Cenovus Energy (TSX: CVE) has agreed to buy ...